Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Rose

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Cancer|February 6, 2009
CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group studyChunqiao Tian, Maurie Markman, Richard Zaino, et al.
Cancer|April 17, 2014
State of the science in cervical cancer: where we are today and where we need to goDon S Dizon, Helen J Mackay, Gillian M Thomas, et al.
Cancer|November 7, 2003
Innovations in the treatment of invasive cervical cancerFrederick B Stehman, Peter G Rose, Benjamin E Greer, et al.
Gynecologic Oncology|December 1, 2015
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group StudyElizabeth R Burton, Mark Brady, Howard D Homesley, et al.
Gynecologic Oncology|July 12, 2021
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian CancerMorgan Gruner, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology|January 20, 2021
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancerAnna Chichura, Laura M Chambers, Anthony B Costales, et al.
Gynecologic Oncology|October 17, 2020
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancerMolly Morton, Laura M Chambers, Anthony B Costales, et al.
Contemporary Clinical Trials|August 21, 2014
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivorsNora L Nock, Anastasia Dimitropoulos, Stephen M Rao, et al.
Gynecologic Oncology|December 17, 2014
Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution studyMohamed A Elshaikh, Zaid Al-Wahab, Haider Mahdi, et al.
Obstetrics and Gynecology|August 3, 2023
Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian CancerMolly Morton, Meng Yao, Julia Chalif, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Cancer|February 6, 2009
CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group studyChunqiao Tian, Maurie Markman, Richard Zaino, et al.
Cancer|April 17, 2014
State of the science in cervical cancer: where we are today and where we need to goDon S Dizon, Helen J Mackay, Gillian M Thomas, et al.
Cancer|November 7, 2003
Innovations in the treatment of invasive cervical cancerFrederick B Stehman, Peter G Rose, Benjamin E Greer, et al.
Gynecologic Oncology|December 1, 2015
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group StudyElizabeth R Burton, Mark Brady, Howard D Homesley, et al.
Gynecologic Oncology|July 12, 2021
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian CancerMorgan Gruner, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology|January 20, 2021
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancerAnna Chichura, Laura M Chambers, Anthony B Costales, et al.
Gynecologic Oncology|October 17, 2020
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancerMolly Morton, Laura M Chambers, Anthony B Costales, et al.
Contemporary Clinical Trials|August 21, 2014
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivorsNora L Nock, Anastasia Dimitropoulos, Stephen M Rao, et al.
Gynecologic Oncology|December 17, 2014
Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution studyMohamed A Elshaikh, Zaid Al-Wahab, Haider Mahdi, et al.
Obstetrics and Gynecology|August 3, 2023
Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian CancerMolly Morton, Meng Yao, Julia Chalif, et al.
Pageof 21